Hepatitis C: all 2,356 studies
Page 9 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected PatientsCompletedNCT00136318Phase 3Results posted
- Cerebral Effects of Pegylated Interferon in Hepatitis C Positive SubjectsCompletedNCT00136214Results posted
- Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver TransplantationCompletedNCT00135798Phase 2Results posted
- Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver TransplantCompletedNCT00135694Phase 2Results posted
- FibroScan in Patients With Hepatitis B and C Presenting for Liver BiopsyCompletedNCT00125762Not applicableResults posted
- Improving Quality of Life for Veterans Undergoing Interferon TreatmentCompletedNCT00117559Not applicableResults posted
- Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.CompletedNCT00107653Phase 4Results posted
- Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)CompletedNCT00104052Phase 3Results posted
- PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis CCompletedNCT00100659Phase 3Results posted
- REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination TherapyCompletedNCT00087646Phase 4Results posted
- PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.CompletedNCT00087633Phase 4Results posted
- Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).CompletedNCT00087607Phase 4Results posted
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.CompletedNCT00087594Phase 4Results posted
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + RibavirinCompletedNCT00087568Phase 4Results posted
- Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected PatientsCompletedNCT00085917Phase 2Results posted
- Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)CompletedNCT00081770Phase 3Results posted
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)CompletedNCT00078403Phase 2Results posted
- ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.CompletedNCT00077636Phase 4Results posted
- Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3CompletedNCT00056862Phase 4Results posted
- Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)CompletedNCT00049842Phase 3Results posted
- Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)CompletedNCT00048724Phase 3Results posted
- PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)CompletedNCT00039871Phase 3Results posted
- Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic VasculitisCompletedNCT00029107Phase 2Results posted
- Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney DiseaseCompletedNCT00028093Phase 4Results posted
- Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected PatientsCompletedNCT00018031Phase 2Results posted
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard TreatmentCompletedNCT00006164Phase 3Results posted
- Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver CirrhosisCompletedNCT07791940Phase 4
- Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver DiseaseCompletedNCT07702396Not applicable
- Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP ScoreCompletedNCT07687758
- Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant DiseasesCompletedNCT07671508Phase 2/3
- Simplified HCV Integrated Management Model in Methadone Clinics in UkraineCompletedNCT07569211Not applicable
- Sofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA TreatmentActive, not recruitingNCT07565948
- SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOFActive, not recruitingNCT07316842
- C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCVActive, not recruitingNCT07037277Phase 3
- HepC Micro-elimination on MSM and TGW Population.CompletedNCT06847958
- Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical TrialActive, not recruitingNCT06842563
- Hepatitis C Prevalence in Men Who Have Sex With MenCompletedNCT06606197
- DBS TaT in Peer-assisted Telemedicine for Hepatitis CActive, not recruitingNCT06409169Not applicable
- Hepatitis C Lab Testing Comparison StudyTerminatedNCT06380166
- Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay UsersCompletedNCT06369116Not applicable
- INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result InterpretationCompletedNCT06357819
- The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral DrugsActive, not recruitingNCT06325826
- HCV Tappt Adherence StudyCompletedNCT06263829Not applicable
- Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis CTerminatedNCT06082336Not applicable
- The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)CompletedNCT06062966Phase 1
- HCV Microfluidic DiagnosticsCompletedNCT06047275
- Study of DAA Treatment for Children and Adolescents With Active HCV Infection in CambodiaActive, not recruitingNCT05992077Not applicable
- Relinking Diagnosed But Untreated HCV Patients Back Into Care.CompletedNCT05975216
- Persuasive Health Communication Intervention for HIV/HCVCompletedNCT05968573Not applicable
- Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver ClinicsActive, not recruitingNCT05895448Phase 4
- Delivering a Multi-disease Screening Tool to Migrant PopulationsCompletedNCT05868005Not applicable
- Community Intervention to Eliminate HCV Among People Who Use Drugs.Active, not recruitingNCT05794646Not applicable
- Hepatitis C Diagnosis to Treatment ManagementCompletedNCT05725109
- Hepatitis C Screening AlertsCompletedNCT05710120
- Multicenter Performance Study of QuadQuik Invitro Diagnostic DeviceStatus unknownNCT05692505
- Buprenorphine Integration Research and Community HealthActive, not recruitingNCT05668780Not applicable
- Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose RiskActive, not recruitingNCT05657106Not applicable
- Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)WithdrawnNCT05649202
- Hepatic Enzymes, Psychological Measures, and Sexual Dysfunction Responses to Aerobic Exercise in Hepatitis-C MenStatus unknownNCT05624086Not applicable
- Effect of New Oral Treatment for Hepatitis C Virus on Seminal ParametersCompletedNCT05616598Phase 2/3
- Efficacy and Safety of Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir Tablets for the Treatment of Chronic HCV Infection: A Prospective, Multi-center Real-world Study.Status unknownNCT05601518
- HCV Test and Treat Utilizing Simplified HCV Patient EducationTerminatedNCT05582681Phase 4
- APPROACH 2.0: HIV, HCV and Syphilis Testing Through PharmaciesActive, not recruitingNCT05534633Not applicable
- Elimination of Hepatitis C Virus Among Users of SubstancesStatus unknownNCT05503979
- Ablation of Hepatocellular Carcinoma: a Nationwide StudyCompletedNCT05498779
- KP-Led Same Day HCV Test and Treat StudyCompletedNCT05479760Not applicable
- Eliminating HCV Infection Among PWUDStatus unknownNCT05474781
- Health and Migration Trajectories of Housekeepers in BamakoCompletedNCT05472051
- Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated CirrhosisStatus unknownNCT05467826Phase 4
- HCV-Smoking Cessation StudyCompletedNCT05466981Not applicable
- Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.CompletedNCT05465434Phase 3
- Implementing HCV Treatment for High-risk Populations in Austin, TexasStatus unknownNCT05460130Not applicable
- Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter StudyCompletedNCT05452187
- Plasma MicroRNA for Prediction of Hepatocellular CarcinomaCompletedNCT05449847
- Hepatitis C Treatment in Probation and Parole OfficeCompletedNCT05413785Not applicable
- EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCVCompletedNCT05412017Not applicable
- Evaluating the Chain of Addiction Care (CAC)Status unknownNCT05401136
- Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis CCompletedNCT05395416Phase 2/3
- Possible Differences in HCC Course Depending on DAA TreatmentStatus unknownNCT05376943
- Treatment of Hepatitis c by Using Direct-acting AntiviralStatus unknownNCT05372874
- Eliminating HCV in Rural South Carolina Utilizing NP Led Mobile Clinics and Virtual Care CoordinationCompletedNCT05369507Not applicable
- Digital Community to Improve Health in Rural AreasCompletedNCT05363865Not applicable
- Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infectionStatus unknownNCT05276700
- ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject DrugsCompletedNCT05270135Not applicable
- Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%CompletedNCT05264558Phase 4
- Tele-Harm ReductionCompletedNCT05208697Not applicable
- Utilization of MAsS in Patients Undergoing LT for HCCTerminatedNCT05184283
- Long Term Follow up of Chronic HCV Patients Receiving DAASStatus unknownNCT05170490
- Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)CompletedNCT05138523
- Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention CenterCompletedNCT05127187Not applicable
- Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSPCompletedNCT05108935Not applicable
- Predictive Power of Share Wave Fibro Scan in HCC After HCV InfectionCompletedNCT05105828
- Screening for Hepatitis C Using a Rapid Diagnostic Orientation Test (TROD) in Patients Over 50 Years Old in the Digestive Endoscopy Department of the Europeen Hospital MarseilleStatus unknownNCT05103085
- Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus InfectionStatus unknownNCT05092074
- Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve ChildrenCompletedNCT05091008Phase 2
- Hepatitis C Screening Paired With MammographyCompletedNCT05067374
- Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action AntiviralsCompletedNCT05062408
- Same-visit Hepatitis C Testing and Treatment (The QuickStart Study)Status unknownNCT05016609Phase 4
- Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)CompletedNCT05002907
- The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in ChinaStatus unknownNCT04997564Phase 4